Clinical Trials Browser

Urinary Bladder Neoplasms

NCT02624388 2024-05-06

UVA-Gen001

Brain Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Neuroectodermal Tumors, Primitive

NCT02567799 2024-01-25

NSCLC

Phase 1/2 Completed

21 enrolled 32 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00244933 2023-06-22

Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer

Phase 2 Completed

19 enrolled 5 charts

Breast

Breast Neoplasms

NCT02766478 2022-09-27

GeniPro

Phase 2 Terminated

10 enrolled 10 charts

Genitourinary

Prostatic Neoplasms

NCT00118040 2021-06-10

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Phase 2 Completed

60 enrolled 24 charts

Genitourinary

Urinary Bladder Neoplasms

NCT00376948 2021-03-01

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 2 Completed

20 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00882765 2020-07-31

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT02075112 2019-12-06

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

Phase 1 Completed

24 enrolled

Head & Neck

Head and Neck Neoplasms

NCT00769990 2017-12-13

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Phase 1/2 Withdrawn

BreastDermatologicGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pain, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00290758 2017-02-08

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Phase 2 Completed

126 enrolled 16 charts

Breast

Breast Neoplasms

NCT01628471 2015-09-23

MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Phase 1/2 Completed

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01182246 2014-04-23

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Phase 1/2 Unknown

44 enrolled

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT00099008 2013-05-21

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

Phase 1 Completed

30 enrolled

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

NCT00058266 2012-07-19

Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy

Phase 2 Terminated

36 enrolled

Genitourinary

Prostatic Neoplasms

NCT00005827 2012-04-24

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Phase 1 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT00546039 2008-09-30

Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer

Phase 2 Unknown

47 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment

UVA-Gen001

NSCLC

Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer

GeniPro

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer

MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer